Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy

Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy

Abstract Background To find semi-quantitative and quantitative Positron Emission Tomography/Magnetic Resonance (PET/MR) imaging metrics of both tumor and non-malignant lymphoid tissue (bone marrow and spleen) for Progression Free Survival (PFS) and Overall Survival (OS) prediction in patients with r...

Full description

Bibliographic Details
Main Authors: Therese Sjöholm, Alexander Korenyushkin, Gustav Gammelgård, Tina Sarén, Tanja Lövgren, Angelica Loskog, Magnus Essand, Joel Kullberg, Gunilla Enblad, Håkan Ahlström
Format: Article
Language:English
Published: BMC 2022-12-01
Series:Cancer Imaging
Subjects:
PET/MR
ADC
FDG
LBCL
CAR T-cells
Bone marrow
Online Access:https://doi.org/10.1186/s40644-022-00513-y

Internet

https://doi.org/10.1186/s40644-022-00513-y

Similar Items